SCHEMBL1744917

SCHEMBL1744917

C#CCn1cccn1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1777383 0.76
SCHEMBL2444396 0.76
SCHEMBL1904553 0.76
SCHEMBL19438929 0.74 DAO (0.36)
SCHEMBL10908855 0.73
SCHEMBL16324771 0.73
SCHEMBL1306770 0.73
SCHEMBL29991984 0.71 DAO (0.34)
SCHEMBL5713341 0.71 DAO (0.50)
SCHEMBL1651954 0.71 FDPS (0.45)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 67 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12319698-B2 Proteasome activity enhancing compounds Kineta, Inc. (US) 2025-06-03 US disclosed
CN-112585132-B Proteasome activity enhancing compounds 优曼尼蒂公司 2025-02-28 CN disclosed
WO-2023118521-A1 DIHYDRO-OXAZOL DERIVATIVE COMPOUNDS AC IMMUNE SA (CH) 2023-06-29 WO disclosed
US-20230183256-A1 PROTEASOME ACTIVITY ENHANCING COMPOUNDS YUMANITY THERAPEUTICS, INC. 2023-06-15 US disclosed
US-11560385-B2 Proteasome activity enhancing compounds PROTEOSTASIS THERAPEUTICS, INC. (US) 2023-01-24 US disclosed
US-11358957-B2 Microbiocidal oxadiazole derivatives SYNGENTA PARTICIPATIONS AG (CH) 2022-06-14 US disclosed
CN-112778377-B Ferrocene burning-rate catalyst containing bis (imidazole or pyrazole-1, 2, 3-triazole) group and preparation method thereof 陕西师范大学 2021-12-24 CN disclosed
CN-112939708-B Imidazole and pyrazole combustion rate catalyst containing ferrocenyl methyl-1, 2, 3-triazolyl group and preparation method thereof 陕西师范大学 2021-11-30 CN disclosed
US-20210188758-A1 PHENOXY ACETIC ACIDS AND PHENYL PROPIONIC ACIDS AS PPAR DELTA AGONISTS VTVX HOLDINGS II LLC 2021-06-24 US disclosed
CN-112939708-A Imidazole and pyrazole combustion rate catalyst containing ferrocenyl methyl-1, 2, 3-triazolyl group and preparation method thereof 陕西师范大学 2021-06-11 CN disclosed
EP-1038880-B1 Androstanes and pregnanes for allosteric modulation of GABA receptor EURO CELTIQUE SA (LU) 2007-10-17 EP disclosed
WO-2007071766-A2 PHENOXY ACETIC ACIDS AS PPAR DELTA ACTIVATORS TRANSTECH PHARMA (US) 2007-06-28 WO disclosed
US-6277838-B1 ADMINISTERING DOSAGE OF ANXIOLYTIC AGENT TO ANIMAL COCENSYS, INC. 2001-08-21 US disclosed
US-6143736-A USED TO ALLEVIATE STRESS, ANXIETY, SEIZURES, MOOD DISORDERS, PREMENSTRUAL SYNDROME(PMS) AND POSTNATAL DEPRESSION (PND AND TO INDUCE ANESTHESIA COCENSYS, INC. (US) 2000-11-07 US disclosed
EP-1038880-A2 Androstanes and pregnanes for allosteric modulation of GABA receptor COCENSYS, INC. (US) 2000-09-27 EP disclosed
EP-0752860-B1 ANDROSTANES AND PREGNANES FOR ALLOSTERIC MODULATION OF GABA RECEPTOR EURO CELTIQUE SA (LU) 2000-08-23 EP disclosed
US-5939545-A MODULATING THE GABA.SUB.A (GAMMA-AMINOBUTYRIC ACID A) RECEPTOR-CHLORIDE IONOPHORE COMPLEX TO ALLEVIATE STRESS, ANXIETY, SEIZURES, MOOD DISORDERS, PMS (PREMENSTRUAL SYNDROME) AND PND (POSTNATAL DEPRESSION) AND TO INDUCE ANESTHESIA COCENSYS, INC. (US) 1999-08-17 US disclosed
EP-0752860-A4 ANDROSTANES AND PREGNANES FOR ALLOSTERIC MODULATION OF GABA RECEPTOR COCENSYS INC (US) 1998-05-06 EP disclosed
EP-0752860-A1 ANDROSTANES AND PREGNANES FOR ALLOSTERIC MODULATION OF GABA RECEPTOR COCENSYS, INC. (US) 1997-01-15 EP disclosed
WO-1995021617-A1 ANDROSTANES AND PREGNANES FOR ALLOSTERIC MODULATION OF GABA RECEPTOR COCENSYS, INC. (US) 1995-08-17 WO disclosed